GATA-3 Recombinant Rabbit Monoclonal Antibody Product Datasheet Catalog# BX50252 Clone# BP6229 Predicted Molecular Wt: 48kDa Purity: ProA affinity purified IgG Species Cross-reactivity: Human Form: Liquid Applications: IHC-P Swissprot ID: P23771 Background: GATA binding protein 3 or GATA-3, is a zinc finger transcription factor and plays an important role in promoting and directing cell proliferation, development, and differentiation in many tissues and cell types. GATA-3 is one of the three genes mutated in 10% of breast cancers. Nuclear expression of GATA-3 in breast cancer is considered a marker of luminal cancer in ER+ cancer and luminalandrogen responsive cancer in ER-/AR+ tumors. It is highly coexpressed with FOXA1 and serves as negative predictor of basal subtype and HER-2 and is also considered a strong predictor of taxane and platin salts insensitivity. GATA-3 expression is found in urothelial carcinoma, especially in invasive and high grade tumors. Therefore, GATA-3 can be used in a panel of antibodies for diagnosis of unknown primary carcinoma, when carcinomas of the breast or bladder area possibility. Studies have also shown the utility of GATA-3 in differntiatingurothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine, cervix, anus and lung. Subcellular location: Nucleus Recommended Method: Heat induced epitope retrieval with Tris-EDTA buffer (pH 9.0), primary antibody incubate at RT (18°C-25°C) for 30 minutes. Immunogen: Synthetic peptide. This information is proprietary to Biolynx. Storage Buffer: PBS 59%, Sodium azide 0.01%, Glycerol 40%, BSA 0.05%. Storage Conditions: -25°C to -18°C Shipment Instructions: Shipped on blue ice. Upon delivery store at -25°C to -18 °C. Avoid freeze / thaw cycles. Recommended Dilution: IHC-P: 1:100-1:200 Background References: 1. Voduc D, et al. Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):365-73. 2. Miettinen M, et al. Am J Surg Pathol. 2014 Jan; 38(1): 13–22. Immunohistochemistry (Formalin/PFA-fixed paraffin- embedded sections) analysis of invasive ductal carcinoma of the breast labelling GATA-3 with BP6229.
您好!请登录